HHS & Georgia Representatives Visit Meridian Clinical Research in Savannah, GA

Oct 18, 2020 | Coronavirus, COVID-19, HHS, Leading Sites, News, Site Success, Site Watch

HHS & Georgia Representatives Visit Meridian Clinical Research in Savannah, GA

Officials from the US Department of Health and Human Services (HHS) visited with leaders from Meridian Clinical Research in Savannah, GA. Following a tour of Meridian’s internal medicine site in Savannah, the group held a roundtable to discuss Meridian’s patient recruitment efforts and the research the company has conducted for COVID-19 vaccine clinical trials.

Attendees included:

HHS

Georgia State Representatives

Meridian Clinical Research

“We’re honored to work with the agencies and organizations reinforcing safety and progress in vaccine research,” said Osborn. “We’ve enrolled thousands in COVID-19 vaccine trials, and we welcome the opportunity to collaborate and share our experience in recruiting patients for these trials.”

Meridian sites were the first in the US to enroll patients in Phase II and III COVID-19 vaccine studies. Operation Warp Speed (OWS) program officials Moncef Slaoui, chief advisor, and General Gustave F. Perna, chief operating officer, also visited Meridian’s internal medicine site in Savannah earlier this year. Meridian is conducting COVID-19 vaccine clinical trials at nine of its 23 sites.

Earlier this month, Meridian won the 2020 Vaccine Industry Excellence (ViE) award for Best Clinical Trial Site. Meridian is also the largest member of the Platinum Research Network, which won the ViE award for Best Clinical Trial Network.

About Meridian Clinical Research

Meridian Clinical Research partners with pharmaceutical and biotechnology companies to research new drugs, medical devices, and diagnostics that could improve human health and wellbeing. Founded in 1999, Meridian is a multi-specialty site network headquartered at its dedicated research center in Omaha, NE, and conducts Phase I-IV studies at investigative sites across North America. Meridian supports research across numerous therapeutic areas and specializes in high-volume vaccine trials. Learn more at mcrmed.com.

Call to Action: Sponsors interested in working with Meridian Clinical Research can contact Andrew Kimball at akimball@mcrmed.com

Source: CISION PRWeb

0 Comments

Submit a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Pin It on Pinterest